These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2268867)

  • 1. A multicenter trial comparing the efficacy and safety of cefuroxime axetil and cefaclor in pneumonia of adults.
    Yangco BG; Lowe J; Nolen TM; Schleupner C; Tan JS; Anthony W
    Clin Ther; 1990; 12(5):440-6. PubMed ID: 2268867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ; Anthony WC; Tan J; File TM; Lifland P; Craig W; Vogelman B
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cefaclor and cefuroxime axetil in the treatment of acute otitis media with effusion in children who failed amoxicillin therapy.
    Turik MA; Johns D
    J Chemother; 1998 Aug; 10(4):306-12. PubMed ID: 9720470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis.
    Sydnor A; Gwaltney JM; Cocchetto DM; Scheld WM
    Arch Otolaryngol Head Neck Surg; 1989 Dec; 115(12):1430-3. PubMed ID: 2510772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefuroxime axetil in the treatment of cutaneous infections.
    Parish LC; Cocchetto DM; Werner K; Jungkind DL; Witkowski J
    Int J Dermatol; 1987; 26(6):389-93. PubMed ID: 3305394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.
    Williams KJ; Hebblethwaite EM; Brown GW; Cox DM; Plested SJ
    Drugs Exp Clin Res; 1987; 13(2):95-9. PubMed ID: 3556123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.
    Iravani A; Richard GA
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1212-6. PubMed ID: 2802549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
    File TM; Segreti J; Dunbar L; Player R; Kohler R; Williams RR; Kojak C; Rubin A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the safety and efficacy of cefuroxime axetil and cefaclor in outpatient management of community-acquired lower respiratory tract infections.
    Nolen TM; Hutchison J; Phillips HL
    J Chemother; 1989 Jul; 1(4 Suppl):768-9. PubMed ID: 16312631
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Clin Ther; 1995; 17(5):861-74. PubMed ID: 8595638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of otitis media with cefuroxime axetil.
    Aronovitz GH
    South Med J; 1988 Aug; 81(8):978-80. PubMed ID: 3043692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
    Dagan R; Abramson O; Leibovitz E; Lang R; Goshen S; Greenberg D; Yagupsky P; Leiberman A; Fliss DM
    Pediatr Infect Dis J; 1996 Nov; 15(11):980-5. PubMed ID: 8933545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of cefuroxime-axetil in the treatment of acute sinusitis in adults. Comparative study with cefaclor].
    Freche C; Fombeur JP; Pappo M
    Therapie; 1988; 43 Suppl 4():365-8. PubMed ID: 3222778
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of lower respiratory tract infections with cefuroxime-axetil. Comparison with cefaclor].
    Pariente R; Rochemaure J; Murciano D; Brechot JM; Pappo M
    Therapie; 1988; 43 Suppl 4():361-4. PubMed ID: 3222777
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of cefuroxime axetil in acute dental infections. Double blind comparative study vs. cefaclor].
    Sasaki I; Morihana T; Kaneko A; Michi K; Takahashi K; Fukuoka F; Satoh T; Yoshinari N; Ohne M; Hara H
    Jpn J Antibiot; 1990 Dec; 43(12):2035-68. PubMed ID: 2086820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
    Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ
    J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of cefaclor AF vs. cefuroxime axetil in acute exacerbations of chronic bronchitis.
    Haczyński J; Chyczewska E; Grzelewska-Rzymowska I; Malolepszy J; Marcinkowska-Suchowierska E; Milanowski J; Oklek K; Płusa T; Słominski J; Szmygin K; Rek M
    Med Sci Monit; 2002 Jan; 8(1):PI1-7. PubMed ID: 11782685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
    Weiss LR
    Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
    Siegert R; Berg O; Gehanno P; Leiberman A; Martinkenas JL; Nikolaidis P; Arvis P; Alefelder M; Reimnitz P
    Eur Arch Otorhinolaryngol; 2003 Apr; 260(4):186-94. PubMed ID: 12709801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.